CINC insider filings
CinCor Pharma, Inc. — 42 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-02-28. Screen CINC transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CINC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — CinCor Pharma, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-02-28 | 4 | 5AM Partners VI, LLC — 10% owner 5AM Ventures VI, L.P. — 10% owner 5AM Opportunities I, L.P. — 10% owner Schwab Andrew J. — 10% owner PARMAR KUSH — 10% owner 5AM Opportunities II (GP), LLC — 10% owner 5AM Opportunities II, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner | Code (U): 3,953,990 · Code (U): 487,333 · Code (U): 496,323 | EDGAR |
| 2023-02-27 | 4 | Freeman Mason — Chief Medical Officer | Sale (S): 6 @ $15.21 · Code (U): 2,494 · Disposition to issuer (D): 40,000 · Code (U): 100 · Disposition to issuer (D): 30,178 (derivative) · Disposition to issuer (D): 145,296 (derivative) · +1 more | EDGAR |
| 2023-02-27 | 4 | HEALY JAMES — Director, 10% owner Katabi Maha — 10% owner Sofinnova Management X, L.P. — 10% owner Sofinnova Management X-A, L.L.C. — 10% owner Sofinnova Venture Partners X, L.P. — 10% owner | Sale (S): 6,000 @ $14.32 · Code (U): 9,803 · Disposition to issuer (D): 19,608 · Code (U): 6,073,949 | EDGAR |
| 2023-02-24 | 4 | Allison David D. — Director | Disposition to issuer (D): 29,411 (derivative) · Disposition to issuer (D): 1,038 (derivative) · Disposition to issuer (D): 881 (derivative) · Disposition to issuer (D): 524 (derivative) · Disposition to issuer (D): 1,499 (derivative) | EDGAR |
| 2023-02-24 | 4 | Pearce Catherine — Chief Operating Officer | Code (U): 140,149 · Disposition to issuer (D): 15,000 · Code (U): 1,500 · Disposition to issuer (D): 110,136 (derivative) · Disposition to issuer (D): 13,236 (derivative) | EDGAR |
| 2023-02-24 | 4 | de Garidel Marc — Chief Executive Officer, Director | Code (U): 12,500 · Disposition to issuer (D): 200,000 · Disposition to issuer (D): 726,483 (derivative) · Disposition to issuer (D): 601,901 (derivative) | EDGAR |
| 2023-02-24 | 4 | Lee June — Director | Disposition to issuer (D): 47,954 (derivative) | EDGAR |
| 2023-02-24 | 4 | Kalb Michael Wayne — EVP & Chief Financial Officer | Disposition to issuer (D): 202,437 · Disposition to issuer (D): 77,615 (derivative) | EDGAR |
| 2023-02-24 | 4 | Ignelzi Troy A. — Director | Disposition to issuer (D): 36,324 (derivative) · Disposition to issuer (D): 58,823 (derivative) | EDGAR |
| 2023-02-24 | 4 | THERO JOHN F — Director | Disposition to issuer (D): 36,324 (derivative) · Disposition to issuer (D): 58,823 (derivative) | EDGAR |
| 2023-01-30 | 4 | de Garidel Marc — Chief Executive Officer, Director | Grant/award (A): 200,000 | EDGAR |
| 2023-01-30 | 4 | Pearce Catherine — Chief Operating Officer | Grant/award (A): 15,000 | EDGAR |
| 2023-01-30 | 4 | Freeman Mason — Chief Medical Officer | Grant/award (A): 40,000 | EDGAR |
| 2023-01-30 | 4 | Kalb Michael Wayne — EVP & Chief Financial Officer | Grant/award (A): 177,000 | EDGAR |
| 2023-01-19 | 4 | Pearce Catherine — Chief Operating Officer | Option exercise (M): 13,235 · Tax withholding (F): 3,997 @ $28.75 · Option exercise (M): 13,235 (derivative) @ $0 | EDGAR |
| 2023-01-10 | 4 | Allison David D. — Director | Grant/award (A): 1,499 (derivative) @ $8.34 | EDGAR |
| 2022-11-08 | 4 | Kalb Michael Wayne — EVP & Chief Financial Officer | Grant/award (A): 25,437 @ $0 · Grant/award (A): 77,615 (derivative) @ $0 | EDGAR |
| 2022-10-12 | 4 | Allison David D. — Director | Grant/award (A): 524 (derivative) @ $23.85 | EDGAR |
| 2022-08-17 | 4 | 5AM Partners VI, LLC — 10% owner 5AM Ventures VI, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner Schwab Andrew J. — 10% owner PARMAR KUSH — 10% owner 5AM Opportunities II (GP), LLC — 10% owner 5AM Opportunities II, L.P. — 10% owner | Purchase (P): 112,667 @ $30 · Purchase (P): 487,333 @ $30 | EDGAR |
| 2022-08-17 | 4 | Sofinnova Partners SAS — 10% owner Sofinnova Capital IX — 10% owner | Purchase (P): 133,333 @ $30 | EDGAR |
| 2022-08-15 | 4 | Sofinnova Venture Partners X, L.P. — 10% owner Sofinnova Management X, L.L.C. — 10% owner Katabi Maha — 10% owner | Purchase (P): 500,000 @ $30 | EDGAR |
| 2022-08-15 | 4 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. — 10% owner GAP (Bermuda) L.P. — 10% owner GAP Coinvestments CDA, L.P. — 10% owner General Atlantic (CIN), L.P. — 10% owner General Atlantic (SPV) GP, LLC — 10% owner | Purchase (P): 83,000 @ $30 | EDGAR |
| 2022-08-15 | 4 | HEALY JAMES — Director, 10% owner | Purchase (P): 500,000 @ $30 · Purchase (P): 6,000 @ $30 | EDGAR |
| 2022-08-15 | 4 | GENERAL ATLANTIC, L.P. — 10% owner GENERAL ATLANTIC GENPAR, L.P. — 10% owner General Atlantic Partners 100, L.P. — 10% owner GAP COINVESTMENTS III, LLC — 10% owner GAP COINVESTMENTS IV, LLC — 10% owner GAP Coinvestments V, LLC — 10% owner General Atlantic Partners (Bermuda) EU, L.P. — 10% owner General Atlantic Partners (Lux), SCSp — 10% owner General Atlantic (Lux) S.a r.l. — 10% owner General Atlantic GenPar (Lux) SCSp — 10% owner | Purchase (P): 83,000 @ $30 | EDGAR |
| 2022-08-08 | 4 | HEALY JAMES — Director, 10% owner | Option exercise (M): 29,411 @ $13.60 · Option exercise (M): 29,411 (derivative) @ $0 | EDGAR |
| 2022-07-20 | 4 | Allison David D. — Director | Grant/award (A): 881 (derivative) @ $14.19 | EDGAR |
| 2022-07-20 | 4/A | Allison David D. — Director | Grant/award (A): 1,038 (derivative) @ $12.04 | EDGAR |
| 2022-05-11 | 4 | Allison David D. — Director | Grant/award (A): 1,038 (derivative) @ $0 | EDGAR |
| 2022-01-13 | 4 | CinRx Pharma, LLC — 10% owner | Conversion (C): 1,222,530 · Conversion (C): 2,142,856 (derivative) @ $0 · Conversion (C): 2,013,749 (derivative) @ $0 | EDGAR |
| 2022-01-13 | 4 | Pearce Catherine — Chief Operating Officer | Purchase (P): 750 @ $16 · Purchase (P): 1,500 @ $16 | EDGAR |
| 2022-01-13 | 4 | de Garidel Marc — Chief Executive Officer, Director | Purchase (P): 12,500 @ $16 | EDGAR |
| 2022-01-13 | 4/A | Pearce Catherine — Chief Operating Officer | Grant/award (A): 26,471 (derivative) @ $0 | EDGAR |
| 2022-01-13 | 4 | Freeman Mason — EVP Clinical Development | Purchase (P): 2,500 @ $16 · Purchase (P): 100 @ $16 | EDGAR |
| 2022-01-13 | 4 | Coelho Mary Theresa — EVP CFO & Chief BD Officer | Purchase (P): 100 @ $16 | EDGAR |
| 2022-01-13 | 4 | Sofinnova Venture Partners X, L.P. — 10% owner Sofinnova Management X, L.L.C. — 10% owner Katabi Maha — 10% owner | Conversion (C): 5,248,949 · Purchase (P): 325,000 @ $16 · Conversion (C): 13,571,428 (derivative) @ $0 · Conversion (C): 4,275,000 (derivative) @ $0 | EDGAR |
| 2022-01-13 | 4 | 5AM Partners VI, LLC — 10% owner 5AM Ventures VI, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner 5AM Opportunities I, L.P. — 10% owner Schwab Andrew J. — 10% owner PARMAR KUSH — 10% owner | Conversion (C): 3,683,823 · Conversion (C): 183,823 · Purchase (P): 157,500 @ $16 · Purchase (P): 312,500 @ $16 · Conversion (C): 9,999,999 (derivative) @ $0 · Conversion (C): 2,525,000 (derivative) @ $0 · +1 more | EDGAR |
| 2022-01-13 | 4 | Sofinnova Partners SAS — 10% owner Sofinnova Capital IX — 10% owner | Conversion (C): 3,867,646 · Purchase (P): 220,000 @ $16 · Conversion (C): 9,999,999 (derivative) @ $0 · Conversion (C): 3,150,000 (derivative) @ $0 | EDGAR |
| 2022-01-13 | 4 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. — 10% owner GAP (Bermuda) L.P. — 10% owner GAP Coinvestments CDA, L.P. — 10% owner General Atlantic (CIN), L.P. — 10% owner General Atlantic (SPV) GP, LLC — 10% owner | Conversion (C): 2,426,470 · Purchase (P): 1,700,000 @ $16 · Conversion (C): 8,250,000 (derivative) | EDGAR |
| 2022-01-13 | 4 | HEALY JAMES — Director, 10% owner | Conversion (C): 5,248,949 · Purchase (P): 325,000 @ $16 · Conversion (C): 13,571,428 (derivative) @ $0 · Conversion (C): 4,275,000 (derivative) @ $0 | EDGAR |
| 2022-01-13 | 4 | GENERAL ATLANTIC, L.P. — 10% owner GENERAL ATLANTIC GENPAR, L.P. — 10% owner General Atlantic Partners 100, L.P. — 10% owner GAP COINVESTMENTS III, LLC — 10% owner GAP COINVESTMENTS IV, LLC — 10% owner GAP Coinvestments V, LLC — 10% owner General Atlantic Partners (Bermuda) EU, L.P. — 10% owner General Atlantic Partners (Lux), SCSp — 10% owner General Atlantic (Lux) S.a r.l. — 10% owner General Atlantic GenPar (Lux) SCSp — 10% owner | Conversion (C): 2,426,470 · Purchase (P): 1,700,000 @ $16 · Conversion (C): 8,250,000 (derivative) | EDGAR |
| 2022-01-10 | 4 | Pearce Catherine — Chief Operating Officer | Grant/award (A): 26,471 (derivative) @ $0 | EDGAR |
| 2022-01-10 | 4 | Lee June — Director | Grant/award (A): 47,954 (derivative) @ $0 | EDGAR |
Recent 8-K events — CinCor Pharma, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-02-24 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-21 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-04 | 8-K/A | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CINC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs